ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 05-02-2017, 09:06 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,270
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,270
15 yr Member
Exclamation MT Pharma Presents Data on Edaravone for ALS at 2017 AAN Meeting

MT Pharma Presents Data on Edaravone for ALS at 2017 AAN Meeting

Edaravone Data for ALS to Be Presented by MT Pharma at AAN Meeting
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
aan, als, data, meeting, pharma


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
12-month Edaravone Clinical Study Data in ALS Presented at the 27th International Sym MuonOne ALS News & Research 0 12-09-2016 01:44 PM
International Stem Cell Presents Preclinical Parkinson's Disease Data Tupelo3 Parkinson's Disease 1 11-19-2014 10:17 AM
AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Va badboy99 Parkinson's Disease 16 07-31-2014 08:08 PM
May2009: Ceregene Presents Additional Clinical Data Phase 2 Trial of CERE-120 for PD Stitcher Parkinson's Disease 2 05-27-2009 12:54 PM


All times are GMT -5. The time now is 11:18 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.